UNINO Healthcare Private Limited, supported by DRISHTI CPS under the Seed Support scheme, has developed a solution for chest drain management. Their innovative product, PleuraGoh®, is a comprehensive chest tube management system that provides both improved patient care and early diagnosis capabilities. This advanced technology addresses the significant global challenge of chest drain complications, which affect millions of patients worldwide undergoing over 125 million chest drain procedures annually.
PleuraGoh® stands out in the market with its unique approach to chest tube management. The system works by combining antimicrobial properties with innovative design, effectively reducing the risk of infection, air leaks, and tube dislodgement. With its potential to significantly reduce complications and re-interventions, PleuraGoh® offers a safer and more effective alternative to conventional methods.
The PleuraGoh® system comprises two key components, patch and drain, each addressing specific aspects of chest drain management. The PleuraGoh® patch provides sutureless securement with antimicrobial properties. The PleuraGoh® Drain integrates IoT and AI technologies for remote monitoring, controlled auto-suctioning, and automatic charting. Additionally, the system incorporates novel filters that enable rapid point-of-care diagnostics, reducing diagnosis time to just 4-6 hours.
With the support of DRISHTI CPS in funding and development opportunities, UNINO is well-positioned to make a lasting impact on global healthcare. As UNINO continues to refine its technology and explore partnerships with healthcare providers, PleuraGoh® offers new hope to millions of patients undergoing chest drain procedures, aiming to improve their recovery and reduce complications.
Why we invested in UNINO: Our decision was driven by several key factors including their product, PleuraGoh®, which offers a comprehensive and innovative solution addressing critical issues in patient care and early diagnosis. The global market for chest drain procedures presents a significant opportunity for growth and the social impact of reducing complications, improving patient outcomes, and potentially lowering healthcare costs aligns with our mission to support technologies that can make a widespread positive difference. Through our support, we aim to accelerate UNINO’s growth and help bring this innovative technology to healthcare providers and patients worldwide, contributing to improved global health outcomes.